These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The efficacy and safety of ezetimibe for treatment of dyslipidemia after heart transplantation. Crespo-Leiro MG, Paniagua MJ, Marzoa R, Grille Z, Naya C, Flores X, Rodriguez JA, Mosquera V, Franco R, Castro-Beiras A. Transplant Proc; 2008 Nov; 40(9):3060-2. PubMed ID: 19010194 [Abstract] [Full Text] [Related]
5. Effect of ezetimibe in patients who cannot tolerate statins or cannot get to the low density lipoprotein cholesterol target despite taking a statin. Gazi IF, Daskalopoulou SS, Nair DR, Mikhailidis DP. Curr Med Res Opin; 2007 Sep; 23(9):2183-92. PubMed ID: 17692154 [Abstract] [Full Text] [Related]
13. Efficacy and tolerability of fluvastatin XL 80 mg alone, ezetimibe alone, and the combination of fluvastatin XL 80 mg with ezetimibe in patients with a history of muscle-related side effects with other statins. Stein EA, Ballantyne CM, Windler E, Sirnes PA, Sussekov A, Yigit Z, Seper C, Gimpelewicz CR. Am J Cardiol; 2008 Feb 15; 101(4):490-6. PubMed ID: 18312764 [Abstract] [Full Text] [Related]
14. Usefulness of statin-ezetimibe combination to reduce the care gap in dyslipidemia management in patients with a high risk of atherosclerotic disease. Teoh H, Mendelsohn AA, Goodman SG, Jaffer S, Chen RY, Tjia S, Theriault L, Langer A, Leiter LA, Guidelines Based Undertaking for Improvement in Dyslipidemia Related Events (GUIDE) Investigators. Am J Cardiol; 2009 Sep 15; 104(6):798-804. PubMed ID: 19733714 [Abstract] [Full Text] [Related]
17. Reduction in estimated risk for coronary artery disease after use of ezetimibe with a statin. Sampalis JS, Bissonnette S, Habib R, Boukas S, Ezetrol Add-On Investigators. Ann Pharmacother; 2007 Sep 15; 41(9):1345-51. PubMed ID: 17666579 [Abstract] [Full Text] [Related]